Literature DB >> 6861787

Comparative quality control of 99mTc-Pyrophosphate and 99mTc-diphosphonate radiopharmaceuticals.

V Jovanović, T Maksin, M Rastovac, J Bzenić.   

Abstract

The results of analysis of 99mTc-Pyrophosphate (99mPyP), taken as a representative of the group of compounds having an organic P-O-P bond, and of the three diphosphonate compounds: methylene diphosphonate (MDP), 2,3-dicarboxy propane diphosphonate (DPD) and ethane-1-hydroxy-1, 1-diphosphonate (EHDP), which differ in their chemical structure, are shown. Also, some physicochemical parameters such as chloroform-water apparent partition coefficient, the osmotic pressure and pH values in final preparations were studied. The radiochemical purity of these radiopharmaceuticals was determined by the two methods: Sephadex chromatography for separation of 99mTc-hydrolysate and TLC on silica gel with 85% methanol for the determination of free 99mTcO-4. The yield of labelling for both methods was over 90%. Also, pharmacokinetic parameters such as binding to the plasma proteins and to erythrocytes were determined. 99mTc-PyP binding to plasma proteins was higher than the binding of diphosphonate compounds. The quantitative distribution of preparations was determined in experimental animals.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6861787     DOI: 10.1007/bf00252891

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  2 in total

1.  Clinical assessment of the importance of the quantity of tin in commercial bone imaging kits.

Authors:  G T Krishnamurthy; M Tubis; P Joe; W H Bland
Journal:  J Nucl Med       Date:  1978-05       Impact factor: 10.057

2.  Binding of technetium-99m to plasma proteins: influence on the distribution of Tc-99m phosphate agents.

Authors:  C Schümichen; K Koch; A Kraus; G Kuhlicke; K Weiler; A Wenn; G Hoffman
Journal:  J Nucl Med       Date:  1980-11       Impact factor: 10.057

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.